Help desk Your check sheet
Bring better questions to the visit.
You're ready to compare care. A service has your attention, but some answers are still missing.
Write down any questions that still need answers. Use this guide's check sheet to ask about the person, the product and the whole cost before paying.
Begin with the namesKeep asking until each answer is clear.
A polished page has caught your eye. Now look for a record you can check.
Check the clinician and the pharmacy
A clinician is a health professional who reviews your health and talks over treatment with you. A licence is official permission to practise. Ask for their full name and which state board holds their licence.
A state medical board issues doctors' licences and keeps public records showing if each licence remains valid.
Those records also list any action against a doctor who has broken the rules.
Match the name in the board's own record and check whether the licence is still valid.
Telehealth is care provided through video, phone calls or an exchange of messages online.
As of September 26, 2026, a doctor needed a licence or valid permission in the state where the patient was during telehealth care.
Pharmacies have separate state licence records.
Ask which pharmacy will send the medicine. Search its name in your state's pharmacy records.
The US Food and Drug Administration (FDA) says to avoid an online pharmacy unless it appears in that state's records.
Finding the pharmacy's licence does not prove that all of its work meets the rules.
Tick a check when you have its answer
What if the visit starts with a form? Ask what happens after you send it.
A visit needs room for questions
A group of state medical boards said that an online form with only set questions and answers was not enough, as of September 26, 2026.
That guidance calls for enough health history and a chance for patients to raise further questions.
Ask whether the clinician can come back with more questions after reading your answers.
The group's advice does not replace each state's law.
State rules differ, as of September 26, 2026; using a form to ask about your health is not banned in every state.
A prescription tells which medicine a health professional with the right licence has ordered.
- Who reviews my health history?
- Can the clinician ask me more questions, and can I ask mine?
- How would you arrange a test or an exam if needed?
- What happens if this medicine is not a fit?
- What care and answers can I get after the visit?
A small headline price catches your eye. Ask what it includes and how long it lasts.
Ask for the whole cost
Cash price means the amount paid without insurance.
A vial is a small bottle of medicine; KwikPen is a pen that gives medicine by injection, or a shot.
KwikPen holds medicine for several injections by the same person; “single patient” means the pen is not shared.
As of September 26, 2026, the maker priced Zepbound (tirzepatide) vials and KwikPen at $299–$699 for a monthly supply.
The price depended on the prescribed strength and the offer terms.
The strength is the amount of medicine shown on the package. A milligram (mg) is a unit used to measure that amount. The figures below identify prices; ask the clinician which strength is prescribed.
The $449 monthly offer applied to strengths marked 7.5 mg, 10 mg, 12.5 mg and 15 mg, as of September 26, 2026.
To keep that price, each refill had to be completed within 45 days after the previous supply arrived.
If the refill was later, the regular monthly price was $499 for 7.5 mg and $699 for 10, 12.5 or 15 mg.
December 31, 2026, is the end date in the printed savings terms; prices after that date need to be checked again.
Ask whether the price is for medicine in vials, a KwikPen or another type of pen. Ask for medicine costs and care charges to be written separately.
Leave space for each charge
| Visit | What is charged if no prescription is issued? |
|---|---|
| Medicine | Is it included? Which medicine, and does it come in a bottle or a pen? |
| Ongoing care | Is there a membership or a commitment? |
| Extras | What do tests, delivery and supplies add? |
| Later | What is charged after an offer ends? How do I cancel? |
If insurance is involved
Give your plan the product's exact name and the reason for treatment when asking about coverage.
Your plan's list of medicines is its formulary; prior authorization is the plan's required agreement before it pays.
Medicare GLP-1 Bridge is the name of a temporary program with separate payment rules for certain weight-loss medicines.
GLP-1 is part of the program's name and refers to the type of medicine it includes.
As of September 26, 2026, the program set a $50 monthly payment for people who qualify.
That payment is called a copay: the person's share of the medicine cost.
For tirzepatide, Zepbound KwikPen was the only included product; July 1, 2026, was the program's start date, and December 31, 2027, its end date.
Whether you qualify depends on your health and your Medicare plan, as of September 26, 2026.
A Medicare drug plan normally limits how much you pay in a year for medicines the plan covers.
The Bridge's $50 monthly payments do not count toward that limit, as of September 26, 2026.
Those payments are extra spending; they do not bring you closer to the point when you stop paying for other covered medicines that year.
Ask your plan how these separate payments would affect your whole medicine bill.
A listed price does not settle what your own plan will pay.
Cash figures above come from the maker's advertised terms. They are a point to check, not a quote for your care.
You're asked for your health history. Make room for details that could change the decision.
Health details to raise
The product label is the medicine's official information about its uses and risks.
As of September 26, 2026, common problems in Zepbound's label included feeling sick, vomiting, loose stools and trouble passing stools.
The thyroid is a small organ in the front of the neck. A tumor is a growth in the body.
Both tirzepatide labels carry a boxed warning, their strongest warning, about thyroid tumors seen in rats.
Whether this happens in people is not known, in label information checked September 26, 2026.
On September 26, 2026, the labels barred use with MEN 2 or medullary thyroid cancer in either your own or your family's history.
Medullary thyroid cancer is the rare cancer named in that warning; MEN 2 is a rare condition passed through families.
On September 26, 2026, the labels also ruled out use after a serious allergic reaction caused by tirzepatide or any of its ingredients.
Tirzepatide can make birth control pills less effective, according to label information checked September 26, 2026.
- What do my own and my family's health histories change?
- How do past stomach problems affect the decision?
- What do pregnancy plans or birth control pills change?
- How do my other medicines, eye problems or an upcoming operation affect the plan?
- Which symptoms need prompt help, and whom do I reach?
These questions follow concerns in the product labels; they do not decide whether the medicine is a fit for you.
The page is friendly, but its product or care plan is still unclear. Keep the payment page closed while you check.
Reasons to pause
As of September 26, 2026, prescription medicines needed a licensed health professional's order under US law.
Claims that compounded tirzepatide is an approved generic were false as of September 26, 2026.
FDA's advice as of September 26, 2026, was to avoid weight-loss products labelled “for research purposes”.
Those words mean for study. They do not mean a visit as part of a medical study.
Leave these questions open until the service answers them:
- Why is the pharmacy's name missing?
- Why does its licence record not match the name given?
- Who answers health questions after the medicine arrives?